Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Jubilant Pharmova Gains 5%; BSE HEALTHCARE Index Up 0.1%
Tue, 15 Oct 13:55

Jubilant Pharmova Gains 5%; BSE HEALTHCARE Index Up 0.1%Image source: Sefa Ozel/www.istockphoto.com

Jubilant Pharmova share price has zoomed 5% and is presently trading at Rs 1,205.9.

Meanwhile, the BSE HEALTHCARE index is at 44,694.3 (up 0.1%).

Among the top gainers in the BSE HEALTHCARE index today are FDC (up 4.2%) and FORTIS HEALTHCARE (up 2.9%).

Natco Pharma (down 2.6%) and GLAND PHARMA (down 2.4%) are among the top losers today.

Over the last one year, Jubilant Pharmova has moved up from Rs 416.4 to Rs 1,205.9, registering a gain of Rs 789.5 (up 189.6%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,152.0 to 44,694.3, registering a gain of 58.8% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 189.6%), Glenmark Pharma (up 131.5%) and SUVEN PHARMACEUTICALS (up 111.6%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 81,792.2 (down 0.2%).

The top losers among the BSE Sensex today are Bajaj Finance (down 2.5%) and JSW Steel (down 2.0%). The most traded stocks in the BSE Sensex are Tata Steel and Reliance Ind..

In the meantime, NSE Nifty is at 25,051.9 (down 0.3%). Bajaj Auto and Wipro are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 66,473.1 to 81,792.2, registering a gain of 15,319.2 points (up 23.0%).

Jubilant Pharmova Financial Update...

Jubilant Pharmova net profit grew 6410.8% YoY to Rs 4,818 million for the quarter ended June 2024, compared to a profit of Rs 74 million a year ago. Net sales rose 9.1% to Rs 17,317 million during the period as against Rs 15,869 million in April-June 2023.

For the year ended March 2024, Jubilant Pharmova reported 212.0% increase in net profit to Rs 727 million compared to net loss of Rs 649 million during FY23. Revenue of the company grew 6.7% to Rs 67,029 million during FY24.

The current Price to earnings ratio of Jubilant Pharmova, based on rolling 12 month earnings, stands at 36.7.


Equitymaster requests your view! Post a comment on "Jubilant Pharmova Gains 5%; BSE HEALTHCARE Index Up 0.1%". Click here!